CANADA LIFE ASSURANCE Co - ARROWHEAD PHARMACEUTICALS IN ownership

ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 88 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q2 2016. The put-call ratio across all filers is 1.30 and the average weighting 0.0%.

Quarter-by-quarter ownership
CANADA LIFE ASSURANCE Co ownership history of ARROWHEAD PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$2,268
-18.0%
84,553
+9.2%
0.01%
-28.6%
Q2 2023$2,766
+30.5%
77,417
-7.2%
0.01%
+40.0%
Q1 2023$2,119
-26.5%
83,421
+17.3%
0.01%
-37.5%
Q4 2022$2,883
-99.9%
71,130
+11.4%
0.01%
+33.3%
Q3 2022$2,109,000
-7.7%
63,827
-1.6%
0.01%0.0%
Q2 2022$2,284,000
-15.4%
64,892
+13.5%
0.01%0.0%
Q1 2022$2,699,000
-21.9%
57,154
+9.4%
0.01%
-14.3%
Q4 2021$3,457,000
+12.3%
52,255
+6.8%
0.01%0.0%
Q3 2021$3,078,000
-7.2%
48,916
+22.1%
0.01%
-12.5%
Q2 2021$3,318,000
+25.8%
40,075
+0.6%
0.01%
+33.3%
Q1 2021$2,638,000
-20.0%
39,836
-7.3%
0.01%0.0%
Q4 2020$3,298,000
+59.7%
42,993
-10.5%
0.01%
+50.0%
Q3 2020$2,065,000
-13.8%
48,050
-13.5%
0.00%
-20.0%
Q2 2020$2,396,000
+55.5%
55,542
+3.8%
0.01%
+25.0%
Q1 2020$1,541,000
-48.9%
53,518
+11.7%
0.00%
-42.9%
Q4 2019$3,017,000
-10.6%
47,920
-62.4%
0.01%
-12.5%
Q2 2019$3,376,000
+1477.6%
127,402
+989.1%
0.01%
+700.0%
Q1 2019$214,000
+130.1%
11,698
+50.3%
0.00%
Q4 2018$93,000
-37.6%
7,7820.0%0.00%
Q3 2018$149,000
+40.6%
7,7820.0%0.00%
Q2 2018$106,000
+863.6%
7,782
+36.5%
0.00%
Q1 2017$11,000
+22.2%
5,7000.0%0.00%
Q4 2016$9,000
-89.3%
5,700
-50.0%
0.00%
Q3 2016$84,000
+180.0%
11,400
+100.0%
0.00%
Q2 2016$30,0005,7000.00%
Other shareholders
ARROWHEAD PHARMACEUTICALS IN shareholders Q2 2016
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 908,474$24,410,69622.12%
Western Financial Corp/CA 820,239$22,039,82216.16%
JOHNSON & JOHNSON 247,598$6,652,9582.45%
WEALTH EFFECTS LLC 164,750$4,426,8352.19%
M28 Capital Management LP 67,400$1,811,0382.08%
Privium Fund Management B.V. 259,036$6,960,2982.07%
Evolutionary Tree Capital Management, LLC 51,266$1,377,5171.78%
Avidity Partners Management LP 1,063,897$28,586,9121.15%
SECTORAL ASSET MANAGEMENT INC 157,552$4,233,4220.82%
Vivo Capital, LLC 137,411$3,692,2340.40%
View complete list of ARROWHEAD PHARMACEUTICALS IN shareholders